Page last updated: 2024-08-23

nicorandil and Cardio-Renal Syndrome

nicorandil has been researched along with Cardio-Renal Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Du, X; Li, L; Ma, Z; Zhong, X	1

Trials

1 trial(s) available for nicorandil and Cardio-Renal Syndrome

Article	Year
Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome. Journal of cardiovascular pharmacology, 2021, 09-29, Volume: 78, Issue:5 Topics: Aged; Aged, 80 and over; Biomarkers; Cardio-Renal Syndrome; Cardiovascular Agents; China; Coronary Disease; Creatinine; Cystatin C; Female; Functional Status; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-18; Kidney; Lipocalin-2; Male; Middle Aged; Natriuretic Peptide, Brain; Nicorandil; Prospective Studies; Recovery of Function; Time Factors; Treatment Outcome; Ventricular Function, Left	2021

Article

Year

Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome.

Journal of cardiovascular pharmacology, 2021, 09-29, Volume: 78, Issue:5

Topics: Aged; Aged, 80 and over; Biomarkers; Cardio-Renal Syndrome; Cardiovascular Agents; China; Coronary Disease; Creatinine; Cystatin C; Female; Functional Status; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-18; Kidney; Lipocalin-2; Male; Middle Aged; Natriuretic Peptide, Brain; Nicorandil; Prospective Studies; Recovery of Function; Time Factors; Treatment Outcome; Ventricular Function, Left

2021